Palisade Bio Inc. Stock
Palisade Bio Inc. Stock
With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Palisade Bio Inc..
Based on the current price of 0.34 € the target price of 11 € shows a potential of 3123.92% for Palisade Bio Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Palisade Bio Inc. stock. Criterium "Company culture" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Palisade Bio Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Palisade Bio Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Palisade Bio Inc. | - | - | - | - | - | - | - |
| Gritstone Oncology Inc | 7.500% | 11.232% | -68.154% | -65.271% | -58.692% | -90.436% | - |
| Avid Bioservices Inc | 3.170% | 9.244% | 1.563% | -61.310% | 6.557% | -63.068% | 49.683% |
| Pacira Pharmaceuticals | -0.840% | -2.479% | -8.527% | -39.487% | -20.805% | -53.725% | -32.935% |
Comments
Palisade Bio, Inc. (NASDAQ: PALI) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $22.50 price target on the stock.
Show more
Ratings data for PALI provided by MarketBeat
Palisade Bio, Inc. (NASDAQ: PALI) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $1.50 price target on the stock.
Show more
Ratings data for PALI provided by MarketBeat
Palisade Bio, Inc. (NASDAQ: PALI) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Show more
Ratings data for PALI provided by MarketBeat